Skip to main content

Table 3 Crude and adjusted odds ratios (OR) of T2D occurrence based on logistic regression modelling among patients with SCZ

From: Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study

Variables Crudea Adjustedc
OR (95%CI) Corrected p-value OR (95%CI) p-value
Sex
(Reference group = Female)
1.38 (1.06–1.81) 0.063 1.42 (1.08–1.85)a 0.0112
Psychiatric Medication
(Reference group = FGA)
 SGA 1.27 (0.84–1.93) 0.595 1.27 (0.84–1.93) 0.259
 2-Drug Combination 0.96 (0.69–1.33) 0.937 0.98 (0.71–1.35) 0.885
 ≥3-Drug Combination 1.75 (1.19–2.59)b 0.035 1.81 (1.22–2.69)b 0.003
 Number of hospitalizations 1.00 (0.96–1.03) 0.937 0.99 (0.96–1.03) 0.749
 Duration of SCZ 1.00 (0.98–1.02) 0.960 1.00 (0.98–1.02) 0.975
 Outdoor Physical activity in last week: (reference group = No) 0.62 (0.16–2.38) 0.858 0.71 (0.19–2.66) 0.613
  1. aadjusted for age and BMI
  2. bSignificant predictor of T2D among SCZ patients
  3. cAdjusted for age, BMI, sex, duration of SCZ and number of hospitalizations